TRINITY BIOTECH PLC

TRINITY BIOTECH PLC (NASDAQ:TRIB) is a publicly traded company in the Life Sciences sector. Wiseek monitors TRIB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

• Trinity Biotech Enables Massive Dilution as Lender Converts $85M Debt to Equity for Resale (2026-05-26)
• F-3 Filed for Highly Dilutive Secondary Offering; Company Reports $859K in Recent SEPA Sales Amidst Financial Distress (2026-05-13)
• Trinity Biotech Files F-3 for Secondary Offering of 168M ADSs, Potentially Diluting Shareholders by Over 800% (2026-05-13)
• Trinity Biotech Appoints Commercial Head, Reports Improved Q4 EBITDA Amid Transformation Progress (2026-05-06)
• Trinity Biotech Secures $2.5M Loan, Waives Covenants, and Amends Convertible Note with Highly Dilutive Terms (2026-05-04)

Insider Transactions

TRIB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.